defunct biotechnology companies: mergers and acquisitions, business liquidation, insolvency, renaming

Defunct Biotechnology Companies

Nastech Pharmaceutical, Inc.	renamed	MDRNA, Inc.	2008
Natural Pulping AG	insolvent		2002
NeoGenesis Pharmaceuticals, Inc.	acquired by	Schering-Plough Corp.	2005
NetGenics, Inc.	acquired by	Lion Bioscience AG	2002
Neuroceptor, Inc.	merged to	PainCeptor Pharma Corporation	2004
Neurogenesis Biotech Corp.	renamed	Stem Cell Therapeutics Corp.	2004
Neurologic Gene Therapeutics	acquired by	Cell Genesys Inc.	2001
neuronova Pharmaceuticals AG	renamed	Affectis Pharmaceuticals AG	2005
NeuroSurvival Technologies Ltd.	renamed	Aposense Ltd.	2008
Nexell Therapeutics Inc.	insolvent		2002
NeXstar Pharmaceuticals, Inc..	acquired by	Gilead Sciences, Inc.	1999
Norak Biosciences, Inc.	renamed	Xsira Pharmaceuticals, Inc.	2005
Nortran Pharmaceuticals, Inc.	renamed	Cordiome Pharma Corp.	2001
Novalon Pharmaceutical Corp.	acquired by	Karo Bio AB	2000
Nuada Pharmaceuticals, Inc.	bankrupt		2005
Nucleoid Analog Design AG	merged to	Sirenade Pharmaceuticals AG	2003